Taken together these results demonstrate that the Mxi1 over-expression in glioblastoma cells inhibits cyclin B1 promoter activity through the E-box in a dose-dependent fashion, suggesting that Mxi1 could directly modulate the expression of the endogenous cyclin B1 gene through transcriptional inhibition. This evidence concerns the gene MXI1 and glioblastoma.